GlassScriptPhysician profile
Allyson R Cunningham
NPI 1790254290
$1,808.86
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $578 · 2022: $1,231.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $416.11 | 2021-2022 | |
| Ucb, INC. | $324.26 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $136.33 | 2022 | |
| Abbvie INC. | $122.42 | 2021-2022 | |
| Neurelis, INC. | $102.78 | 2021-2022 | |
| Celgene Corporation | $99.71 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $70.48 | 2021-2022 | |
| Alexion Pharmaceuticals, INC. | $63.58 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $61.34 | 2021-2022 | |
| Jazz Pharmaceuticals INC. | $51.05 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $46.01 | 2021 | |
| Genzyme Corporation | $45.07 | 2021 | |
| Sk Life Science, INC. | $44.54 | 2022 | |
| Eisai INC. | $38.91 | 2022 | |
| Lilly USA, LLC | $35.03 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $28.58 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $25.10 | 2021 | |
| Lundbeck LLC | $24.75 | 2021 | |
| Collegium Pharmaceutical, INC. | $23.15 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.99 | 2022 | |
| Owp Pharmaceuticals, INC. | $18.67 | 2022 | |
| Validus Pharmaceuticals LLC | $12.00 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allyson Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.